ORAL TRANSMUCOSAL NICOTINE DOSAGE FORM

Described here in are oral transmucosal solid dosage forms useful in treating nicotine addiction or as a nicotine substitute or replacement. By virtue of the formulation in combination with nicotine, the dosage forms transmucosally delivers an effective amount of nicotine to the recipient while perm...

Full description

Saved in:
Bibliographic Details
Main Authors HAGUE, BRIAN, AGARWAL, VIKAS, KHANKARI, RAJENDRA, K
Format Patent
LanguageEnglish
French
Published 15.04.2010
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:Described here in are oral transmucosal solid dosage forms useful in treating nicotine addiction or as a nicotine substitute or replacement. By virtue of the formulation in combination with nicotine, the dosage forms transmucosally delivers an effective amount of nicotine to the recipient while permitting the accomplishing of such, and manufacture of such, using a relatively small, convenient and orally comfortable dosage form (e.g., tablet) size. L'invention porte sur des formes pharmaceutiques solides trans-muqueuses buccales utiles dans le traitement de l'addiction à la nicotine ou en tant que substitut ou remplacement de nicotine. Grâce à la formulation en combinaison avec de la nicotine, les formes pharmaceutiques administrent par voie trans-muqueuse une quantité efficace de nicotine au destinataire tout en permettant la réalisation et la fabrication de celle-ci, à l'aide d'une forme pharmaceutique relativement petite, commode et confortable par voie orale (par exemple un comprimé).
Bibliography:Application Number: WO2009US59710